{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T12:38:28Z","timestamp":1763642308626},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Prostate Cancer Prostatic Dis"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1038\/s41391-017-0021-x","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T15:54:48Z","timestamp":1513698888000},"page":"147-152","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Maintenance use of aspirin or other non-steroidal anti-inflammatory drugs (NSAIDs) and prostate cancer risk"],"prefix":"10.1038","volume":"21","author":[{"given":"Yuanjun","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nele","family":"Brusselaers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"21_CR1","doi-asserted-by":"publisher","first-page":"5258","DOI":"10.1073\/pnas.92.12.5258","volume":"92","author":"BN Ames","year":"1995","unstructured":"Ames BN, Gold LS, Willett WC. The causes and prevention of cancer. Proc Natl Acad Sci USA. 1995;92:5258\u201365.","journal-title":"Proc Natl Acad Sci USA."},{"key":"21_CR2","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/nature01322","volume":"420","author":"LM Coussens","year":"2002","unstructured":"Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860\u20137.","journal-title":"Nature."},{"key":"21_CR3","first-page":"455","volume":"4","author":"T Stark","year":"2015","unstructured":"Stark T, Livas L, Kyprianou N. Inflammation in prostate cancer progression and therapeutic targeting. Transl Androl Urol. 2015;4:455\u201363.","journal-title":"Transl Androl Urol."},{"key":"21_CR4","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1159\/000020161","volume":"37","author":"PHF Schatteman","year":"2000","unstructured":"Schatteman PHF, Hoekx L, Wyndaele JJ, Jeuris W, Van Marck E. Inflammation in prostate biopsies of men without prostatic malignancy or clinical prostatitis - Correlation with total serum PSA and PSA density. Eur Urol. 2000;37:404\u201312.","journal-title":"Eur Urol."},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1055-9965.EPI-13-1126","volume":"23","author":"B Gurel","year":"2014","unstructured":"Gurel B, Lucia MS, Thompson IM, Goodman PJ, Tangen CM, Kristal AR, et al. Chronic inflammation in benign prostate tissue is associated with high-grade prostate cancer in the placebo arm of the prostate cancer prevention trial. Cancer Epidem Biomar. 2014;23:847\u201356.","journal-title":"Cancer Epidem Biomar."},{"key":"21_CR6","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1016\/j.juro.2010.12.058","volume":"185","author":"K Fujita","year":"2011","unstructured":"Fujita K, Hosomi M, Tanigawa G, Okumi M, Fushimi H, Yamaguchi S. Prostatic inflammation detected in initial biopsy specimens and urinary pyuria are predictors of negative repeat prostate biopsy. J Urol. 2011;185:1722\u20137.","journal-title":"J Urol."},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1586\/ecp.10.120","volume":"3","author":"KM Knights","year":"2010","unstructured":"Knights KM, Mangoni AA, Miners JO. Defining the COX inhibitor selectivity of NSAIDs: implications for understanding toxicity. Expert Rev Clin Pharmacol. 2010;3:769\u201376.","journal-title":"Expert Rev Clin Pharmacol."},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1053\/gast.1996.v111.pm8690211","volume":"111","author":"S Kargman","year":"1996","unstructured":"Kargman S, Charleson S, Cartwright M, Frank J, Riendeau D, Mancini J, et al. Characterization of prostaglandin G\/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology. 1996;111:445\u201354.","journal-title":"Gastroenterology."},{"key":"21_CR9","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1172\/JCI117620","volume":"94","author":"RC Harris","year":"1994","unstructured":"Harris RC, Mckanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula densa of rat-kidney and increases with salt restriction. J Clin Invest. 1994;94:2504\u201310.","journal-title":"J Clin Invest."},{"key":"21_CR10","first-page":"517","volume":"80","author":"JJ Hirst","year":"1995","unstructured":"Hirst JJ, Teixeira FJ, Zakar T, Olson DM. Prostaglandin endoperoxide-h synthase-1 and synthase-2 messenger-ribonucleic-acid levels in human amnion with spontaneous labor onset. J Clin Endocr Metab. 1995;80:517\u201323.","journal-title":"J Clin Endocr Metab."},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1006\/abbi.1993.1343","volume":"304","author":"Y Hamasaki","year":"1993","unstructured":"Hamasaki Y, Kitzler J, Hardman R, Nettesheim P, Eling TE. Phorbol ester and epidermal growth-factor enhance the expression of 2 inducible prostaglandin-h synthase genes in rat tracheal epithelial-cells. Arch Biochem Biophys. 1993;304:226\u201334.","journal-title":"Arch Biochem Biophys."},{"key":"21_CR12","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM Marzo De","year":"2007","unstructured":"De Marzo AM, Platz EA, Sutcliffe S, Xu JF, Gronberg H, Drake CG, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256\u201369.","journal-title":"Nat Rev Cancer"},{"key":"21_CR13","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0014-5793(95)00930-8","volume":"371","author":"LP Wennogle","year":"1995","unstructured":"Wennogle LP, Liang HB, Quintavalla JC, Bowen BR, Wasvary J, Miller DB, et al. Comparison of recombinant cyclooxygenase-2 to native isoforms - aspirin labeling of the active-site. FEBS Lett. 1995;371:315\u201320.","journal-title":"FEBS Lett."},{"key":"21_CR14","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.jacc.2016.05.083","volume":"68","author":"P Patrignani","year":"2016","unstructured":"Patrignani P, Patrono C. Aspirin and cancer. J Am Coll Cardiol. 2016;68:967\u201376.","journal-title":"J Am Coll Cardiol."},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1741-7015-12-55","volume":"12","author":"Y Liu","year":"2014","unstructured":"Liu Y, Chen J-Q, Xie L, Wang J, Li T, He Y, et al. Effect of aspirin and other non-steroidal anti-inflammatory drugs on prostate cancer incidence and mortality: a systematic review and meta-analysis. BMC Med. 2014;12:55\u201369.","journal-title":"BMC Med."},{"key":"21_CR16","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1158\/1078-0432.CCR-14-2235","volume":"21","author":"AC Vidal","year":"2015","unstructured":"Vidal AC, Howard LE, Moreira DM, Castro-Santamaria R, Andriole GL, Freedland SJ. Aspirin, NSAIDs, and risk of prostate cancer: results from the REDUCE study. Clin Cancer Res. 2015;21:756\u201362.","journal-title":"Clin Cancer Res."},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/ijc.23550","volume":"123","author":"S Bonovas","year":"2008","unstructured":"Bonovas S, Filioussi K, Sitaras NM. Statin use and the risk of prostate cancer: a metaanalysis of 6 randomized clinical trials and 13 observational studies. Int J Cancer. 2008;123:899\u2013904.","journal-title":"Int J Cancer."},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000341977","volume":"90","author":"Y Zhang","year":"2013","unstructured":"Zhang Y, Zang T. Association between statin usage and prostate cancer prevention: a refined meta-analysis based on literature from the years 2005-2010. Urol Int. 2013;90:259\u201362.","journal-title":"Urol Int."},{"key":"21_CR19","unstructured":"Tan P, Zhang C, Wei SY, Tang Z, Gao L, Yang L, et al. Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review. Asian J Androl. 2016; Epub ahead of print (cited 2017 Jul 17). \n                    http:\/\/www.ajandrology.com\/preprintarticle.asp?id=190327\n                    \n                  ."},{"key":"21_CR20","doi-asserted-by":"publisher","first-page":"e46691","DOI":"10.1371\/journal.pone.0046691","volume":"7","author":"D Bansal","year":"2012","unstructured":"Bansal D, Undela K, D\u2019Cruz S, Schifano F, Statin use and risk of prostate cancer: a meta-analysis of observational studies. PLoS ONE.2012;7:e46691","journal-title":"PLoS ONE."},{"key":"21_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3109\/02841868409136026","volume":"23","author":"B Mattsson","year":"1984","unstructured":"Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register - Non-Notified Cancer Cases Recorded on Death Certificates in 1978. Acta Radiol Oncol. 1984;23:305\u201313.","journal-title":"Acta Radiol Oncol."},{"key":"21_CR22","unstructured":"FASS (Farmacevtiska specialiteter i Sverige) [Internet]. 2015. Available from: \n                    www.fass.se\n                    \n                  ."},{"key":"21_CR23","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.5858\/arpa.2012-0490-RA","volume":"137","author":"V Kyriazi","year":"2013","unstructured":"Kyriazi V, Theodoulou E. Assessing the risk and prognosis of thrombotic complications in cancer patients. Arch Pathol Lab Med. 2013;137:1286\u201395.","journal-title":"Arch Pathol Lab Med."},{"key":"21_CR24","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1158\/1940-6207.CAPR-17-0019","volume":"10","author":"EH Allott","year":"2017","unstructured":"Allott EH, Howard LE, Vidal AC, Moreira DM, Castro-Santamaria R, Andriole GL, et al. Statin use, serum lipids, and prostate inflammation in men with a negative prostate biopsy: results from the REDUCE trial. Cancer Prev Res. 2017;10:319\u201325.","journal-title":"Cancer Prev Res."}],"container-title":["Prostate Cancer and Prostatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0021-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41391-017-0021-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:32:59Z","timestamp":1684618379000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41391-017-0021-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1038\/s41391-017-0021-x","relation":{},"ISSN":["1365-7852","1476-5608"],"issn-type":[{"value":"1365-7852","type":"print"},{"value":"1476-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"18 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}